Thomas Greaney

Thomas Greaney

Thomas (Tim) Greaney, JD, is a Visiting Professor of Law at UC Hastings College of the Law in San Francisco and Distinguished Senior Fellow with the UC Hastings/UCSF Consortium on Law, Science & Health Policy. Before joining the Hastings faculty, he was Chester A. Myers Professor of Law and Co-Director of the Center for Health Law Studies at Saint Louis University School of Law. His research focuses on the application of antitrust law to the health care sector, health care financing, and health care law and policy.

He has written over 50 scholarly articles and chapters and is co-author of the nation’s leading health law casebook, HEALTH LAW: CASES, MATERIALS AND PROBLEMS (West, 7th edition 2013) and a treatise on health law, HEALTH LAW (WEST 3RD ED. 2014). He has testified on antitrust issues before the Judiciary Committee of the House of Representatives and has spoken at workshops of the Federal Trade Commission. He has commented on health policy and law issues in The New York Times, The Wall Street Journal and many other publications.

Before entering academia, he served as an Assistant Chief in the Department of Justice Antitrust Division, supervising health care antitrust litigation. Professor Greaney has been named Health Law Professor of the Year by the American Society of Law and Medicine. He has also been a Fulbright Fellow studying European Community competition law in Brussels, Belgium. He received his BA from Wesleyan University and his JD from Harvard Law School.

Columns by Thomas Greaney

Permalink to Time for a New—and Effective—Antitrust

Time for a New—and Effective—Antitrust

9 Aug 2018

Thomas Greaney and Samuel R. Miller

Thomas Greaney and Samuel Miller—both adjunct professors at UC Hastings College of the Law and former attorneys with the Antitrust Division of the US Department of Justice—describe how antitrust law in the United States no longer operates as a legal sword to keep markets competitive, but as a shield to protect large companies from competition. Greaney and Miller call for a renewal of the antitrust enterprise using the best of current economics informed by a realistic appreciation for how markets actually work in the real world.